Announcements Trials
Browse Landscape

Phase

Phase 2 53Phase 1 26Phase 1/2 21Phase 3 16Phase NA 7Phase EARLY_PHASE1 3Phase 4 3

Status

Completed 7Unknown 3Recruiting 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 28Breast Neoplasms 23Neoplasms 21Pancreatic Neoplasms 17Glioma 17Prostatic Neoplasms 16Glioblastoma 16Recurrence 14Leukemia, Myeloid, Acute 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Melanoma 8Lymphoma 8Hematologic Neoplasms 8Lymphoma, B-Cell 7Colorectal Neoplasms 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Advanced Solid Tumors 6Sarcoma 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Interventions

pirtobrutinib 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all
NCT07428707 2026-06-04

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07205315 2026-05-27

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Grit Biotechnology

Phase EARLY_PHASE1 Recruiting
28 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT06636175 2025-07-31

64Cu-LLP2A for Imaging Hematologic Malignancies

Washington University School of Medicine

Phase EARLY_PHASE1 Recruiting
42 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡